These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34713589)

  • 1. Distribution of antiretroviral therapy through private pharmacies and postal courier services during COVID-19 in Botswana: acceptability and reach of two out-of-facility individual differentiated service delivery models.
    Mpofu M; Moyo T; Gilbert M; Dikobe W; Nishimoto L; Katiko G; Batuka J; Satti H; Qambayot M; Mahler H; Kitso L; Marqusee H; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25814. PubMed ID: 34713589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.
    Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Courier delivery of antiretroviral therapy: a cohort study of a South African private-sector HIV programme.
    Ruffieux Y; Folb N; Grimsrud A; Hislop M; Dunn L; Rohner E; Namubiru AM; Chinogurei C; Cornell M; Davies MA; Egger M; Maartens G; Haas AD
    J Int AIDS Soc; 2024 Sep; 27(9):e26360. PubMed ID: 39295119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding access to HIV services during the COVID-19 pandemic-Nigeria, 2020.
    Boyd AT; Jahun I; Dirlikov E; Greby S; Odafe S; Abdulkadir A; Odeyemi O; Dalhatu I; Ogbanufe O; Abutu A; Asaolu O; Bamidele M; Onyenuobi C; Efuntoye T; Fagbamigbe JO; Ene U; Fagbemi A; Tingir N; Meribe C; Ayo A; Bassey O; Nnadozie O; Boyd MA; Onotu D; Gwamna J; Okoye M; Abrams W; Alagi M; Oladipo A; Williams-Sherlock M; Bachanas P; Chun H; Carpenter D; Miller DA; Ijeoma U; Nwaohiri A; Dakum P; Mensah CO; Aliyu A; Oyeledun B; Okonkwo P; Oko JO; Ikpeazu A; Aliyu G; Ellerbrock T; Swaminathan M
    AIDS Res Ther; 2021 Sep; 18(1):62. PubMed ID: 34538268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV service delivery in the time of COVID-19: focus group discussions with key populations in India.
    Pollard R; Gopinath U; Reddy YA; Kumar BR; Mugundu P; Vasudevan CK; Srikrishnan AK; Singh A; McFall AM; Mayer KH; Mehta SH; Solomon SS
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25800. PubMed ID: 34713583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
    Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
    J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Indicators for Subnational Unmet Antiretroviral Therapy Need in the Health System: Updates to the Naomi Model in 2023.
    Esra R; Mmelesi M; Ketlogetswe AT; Wolock TM; Howes A; Nong T; Matlhaga MT; Ratladi S; Ramaabya D; Imai-Eaton JW
    J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e24-e33. PubMed ID: 38180736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria.
    Sanwo O; Iyamu I; Idemudia A; Badru T; Ekponimo S; Oqua D; Makinde OA; Aliyu GG; Kola-Jebutu A; Egwuagu-Pius J; Obiora-Okafo C; Bateganya M; Apera I; Pandey SR; Khamofu H
    PLoS One; 2023; 18(11):e0289507. PubMed ID: 37972145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy in community pharmacies - Implementation and outcomes of a differentiated drug delivery model in Nigeria.
    Asieba IO; Oqua DA; Wutoh AA; Agu KA; Omeh OI; Adeyanju ZA; Adesina A; Agu F; Agada P; Achanya A; Ekechuwu N; Tofade T
    Res Social Adm Pharm; 2021 May; 17(5):842-849. PubMed ID: 32839146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis.
    Jo Y; Rosen S; Sy KTL; Phiri B; Huber AN; Mwansa M; Shakwelele H; Haimbe P; Mwenechanya MM; Lumano-Mulenga P; Nichols BE
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25808. PubMed ID: 34713620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
    PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based differentiated service delivery models incorporating multi-month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: a pooled analysis of two cluster-randomized trials in southern Africa.
    Fatti G; Ngorima-Mabhena N; Tiam A; Tukei BB; Kasu T; Muzenda T; Maile K; Lombard C; Chasela C; Grimwood A
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25819. PubMed ID: 34713614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Home Delivery of Antiretroviral Drugs Ensured Uninterrupted HIV Treatment During COVID-19: Experiences From Indonesia, Laos, Nepal, and Nigeria.
    Hoke T; Bateganya M; Toyo O; Francis C; Shrestha B; Philakone P; Pandey SR; Persaud N; Cassell MM; Wilcher R; Mahler H
    Glob Health Sci Pract; 2021 Dec; 9(4):978-989. PubMed ID: 34933991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
    Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
    J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Effects of the COVID-19 Pandemic on HIV Care Utilization, Service Delivery, and Continuity of HIV Antiretroviral Treatment (ART) in Haiti.
    Celestin K; Allorant A; Virgin M; Marinho E; Francois K; Honoré JG; White C; Valles JS; Perrin G; De Kerorguen N; Flowers J; Balan JG; Koama JBT; Barnhart S; Puttkammer N
    AIDS Behav; 2021 May; 25(5):1366-1372. PubMed ID: 33738698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the integration of telehealth into the same-day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID-19: a mixed-method analysis of real-world data.
    Amatavete S; Lujintanon S; Teeratakulpisarn N; Thitipatarakorn S; Seekaew P; Hanaree C; Sripanjakun J; Prabjuntuek C; Suwannarat L; Phattanathawornkool T; Photisan N; Suriwong S; Avery M; Mills S; Phanuphak P; Phanuphak N; Ramautarsing RA
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25816. PubMed ID: 34713623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
    Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
    BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of differentiated service delivery for HIV treatment in sub-Saharan Africa during COVID-19.
    Grimsrud A; Wilkinson L
    J Int AIDS Soc; 2021 Jun; 24(6):e25704. PubMed ID: 34105884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIBRA trial - Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.
    Amstutz A; Lejone TI; Khesa L; Muhairwe J; Nsakala BL; Tlali K; Bresser M; Tediosi F; Kopo M; Kao M; Klimkait T; Battegay M; Glass TR; Labhardt ND
    Trials; 2019 Aug; 20(1):522. PubMed ID: 31439004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 preparedness at health facilities and community service points serving people living with HIV in Sierra Leone.
    Parmley LE; Hartsough K; Eleeza O; Bertin A; Sesay B; Njenga A; Toure M; Egesimba G; Bah H; Bayoh A; Yakubu A; Morrison EAB; Michaels-Strasser S
    PLoS One; 2021; 16(4):e0250236. PubMed ID: 33857253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.